175 related articles for article (PubMed ID: 24139065)
1. Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma.
Gong F; Peng X; Luo C; Shen G; Zhao C; Zou L; Li L; Sang Y; Zhao Y; Zhao X
Mol Cancer; 2013 Oct; 12(1):125. PubMed ID: 24139065
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma.
Yang WE; Ho CC; Yang SF; Lin SH; Yeh KT; Lin CW; Chen MK
PLoS One; 2016; 11(3):e0152165. PubMed ID: 27031837
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation.
Lei T; Ling X
World J Gastroenterol; 2015 Sep; 21(35):10137-49. PubMed ID: 26401078
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma.
Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L
Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818
[TBL] [Abstract][Full Text] [Related]
6. Proteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2D-DIGE-MS.
Lihong H; Linlin G; Yiping G; Yang S; Xiaoyu Q; Zhuzhu G; Xiaohan Y; Xin Z; Liyan X; Shujuan S
PLoS One; 2014; 9(4):e95121. PubMed ID: 24740010
[TBL] [Abstract][Full Text] [Related]
7. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer.
Kim EK; Song MJ; Jang HH; Chung YS
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333840
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
10. Fructose-bisphosphate aldolase a is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration.
Du S; Guan Z; Hao L; Song Y; Wang L; Gong L; Liu L; Qi X; Hou Z; Shao S
PLoS One; 2014; 9(1):e85804. PubMed ID: 24465716
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Koh HM; Kim DC; Kim YM; Song DH
Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
Sevenich L; Schurigt U; Sachse K; Gajda M; Werner F; Müller S; Vasiljeva O; Schwinde A; Klemm N; Deussing J; Peters C; Reinheckel T
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2497-502. PubMed ID: 20133781
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
14. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
[TBL] [Abstract][Full Text] [Related]
15. CTSB Knockdown Inhibits Proliferation and Tumorigenesis in HL-60 Cells.
Peng S; Yang Q; Li H; Pan Y; Wang J; Hu P; Zhang N
Int J Med Sci; 2021; 18(6):1484-1491. PubMed ID: 33628106
[No Abstract] [Full Text] [Related]
16. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
Vasiljeva O; Korovin M; Gajda M; Brodoefel H; Bojic L; Krüger A; Schurigt U; Sevenich L; Turk B; Peters C; Reinheckel T
Oncogene; 2008 Jul; 27(30):4191-9. PubMed ID: 18345026
[TBL] [Abstract][Full Text] [Related]
17. Comparative proteome analysis of human lung squamous carcinoma using two different methods: two-dimensional gel electrophoresis and iTRAQ analysis.
Zeng GQ; Zhang PF; Li C; Peng F; Li MY; Xu Y; Yu FL; Chen MJ; Yi H; Li GQ; Chen ZC; Xiao ZQ
Technol Cancer Res Treat; 2012 Aug; 11(4):395-408. PubMed ID: 22417063
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B may be a potential biomarker in cervical cancer.
Wu D; Wang H; Li Z; Wang L; Zheng F; Jiang J; Gao Y; Zhong H; Huang Y; Suo Z
Histol Histopathol; 2012 Jan; 27(1):79-87. PubMed ID: 22127599
[TBL] [Abstract][Full Text] [Related]
19. [Comparative proteome analysis of human lung squamous cell carcinoma].
Tang CE; Li C; Xiao ZQ; Zhang XP; Chen ZC; Yi H; Li JL; Duan CJ; Liang SP
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):274-9. PubMed ID: 16875628
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of combined analysis of cytokeratin19 expression and preoperative serum CYFRA21-1 levels in human lung squamous cell carcinoma.
Hanada S; Nishiyama N; Mizuguchi S; Yamano S; Kakehashi A; Wei M; Inoue H; Komatsu H; Chung K; Suehiro S; Wanibuchi H
Osaka City Med J; 2013 Jun; 59(1):35-44. PubMed ID: 23909079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
